Circulatory multi-omics change during acute high-altitude exposure and its relationship with the major high-altitude diseases

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2400094074

Enrollment

Unknown

Registered

2024-12-17

Start date

2025-01-01

Completion date

Unknown

Last updated

2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute High-Altitude Disease

Interventions

Rapid Ascent to High Altitude Group:None

Eligibility

Sex/Gender

Male

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Young adult males planning to undergo rapid ascent to high altitude; 2. Age between 18 and 40 years; 3. Participants have signed a written informed consent.

Exclusion criteria

Exclusion criteria: 1. Malignant Tumors; 2. Suffering from Infectious Diseases; 3. Participants Who Decline to Participate.

Design outcomes

Primary

Measure	Time frame
Echocardiography;Complete Blood Count;Vital Signs;Peripheral Blood Multi-Omics Analysis;Serological Marker Testing;	—

Countries

China

Contacts

Public ContactJun Jin

Second Hospital of the Army Medical University

372534493@qq.com+86 132 7260 5717

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026